ArticleAnalytical chemistry2025
Biochemometric 2D NMR-Based Heterocovariance Analysis: A Targeted Approach for Identifying Bioactive Compounds in Complex Mixtures.
Article in Analytical chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Biochemometric approaches, which integrate bioactivity data with spectroscopic or spectrometric data, offer significant potential to streamline the discovery of bioactive compounds in targeted isolation strategies. However, the complexity of natural extracts and the presence of structurally similar analogs make this process time-consuming and resource intensive. This study introduces a 2D nuclear magnetic resonance (NMR)-based heterocovariance analysis (HetCA) workflow to identify chemical features that correlate positively or negatively with bioactivity in complex mixtures. As a proof-of-concept, the workflow was established using artificially mixed samples of pentacyclic triterpenes which were screened for modulatory activities of the retinoic acid receptor-related orphan receptor gamma (RORγ) and the G protein-coupled bile acid receptor (TGR5). The validated concept was then exemplified using a triterpene-rich
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.